276 related articles for article (PubMed ID: 15170903)
21. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
22. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis.
Suissa S; Hudson M; Ernst P
Arthritis Rheum; 2006 May; 54(5):1435-9. PubMed ID: 16645972
[TBL] [Abstract][Full Text] [Related]
23. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
[TBL] [Abstract][Full Text] [Related]
24. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
Cannon GW; Holden WL; Juhaeri J; Dai W; Scarazzini L; Stang P
J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352
[TBL] [Abstract][Full Text] [Related]
25. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
[TBL] [Abstract][Full Text] [Related]
26. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
27. Leflunomide use in New Zealand. A national prospective post-marketing study.
White DH; Lynskey NV; Jones PB
Intern Med J; 2009 Feb; 39(2):95-102. PubMed ID: 19220542
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
29. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
[TBL] [Abstract][Full Text] [Related]
30. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
31. Leflunomide for the treatment of rheumatoid arthritis.
Olsen NJ; Strand V; Kremer JM
Bull Rheum Dis; 1999; 48(8):1-4. PubMed ID: 10628065
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study.
Ren LM; Li R; Chen LN; Zhu P; Gu F; Sun LY; Zhao JX; Liu XY; Guo JL; Bi LQ; Hao YJ; Zhang ZL; Mei YF; Zhang ZY; Liu HX; Li XF; Luo Y; Fang YF; Li ZG; Su Y
Int J Rheum Dis; 2016 Jul; 19(7):651-7. PubMed ID: 26268935
[TBL] [Abstract][Full Text] [Related]
33. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
Br J Clin Pharmacol; 2004 Aug; 58(2):201-8. PubMed ID: 15255803
[TBL] [Abstract][Full Text] [Related]
34. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
[TBL] [Abstract][Full Text] [Related]
35. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
[TBL] [Abstract][Full Text] [Related]
36. Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.
Van Roon EN; Jansen TL; Mourad L; Houtman PM; Bruyn GA; Griep EN; Wilffert B; Tobi H; Brouwers JR
Br J Clin Pharmacol; 2004 Jun; 57(6):790-7. PubMed ID: 15151525
[TBL] [Abstract][Full Text] [Related]
37. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis.
Hansen KE; Cush J; Singhal A; Cooley DA; Cohen S; Patel SR; Genovese M; Sundaramurthy S; Schiff M
Arthritis Rheum; 2004 Apr; 51(2):228-32. PubMed ID: 15077264
[TBL] [Abstract][Full Text] [Related]
38. Treatment continuation in patients receiving biological agents or conventional DMARD therapy.
Zink A; Listing J; Kary S; Ramlau P; Stoyanova-Scholz M; Babinsky K; von Hinueber U; Gromnica-Ihle E; Wassenberg S; Antoni C; Herzer P; Kekow J; Schneider M; Rau R
Ann Rheum Dis; 2005 Sep; 64(9):1274-9. PubMed ID: 15708884
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
[TBL] [Abstract][Full Text] [Related]
40. Leflunomide.
Cannon GW; Kremer JM
Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]